Additional file 1 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

Additional file 1. Supplementary Tables 1-4 and 7-15. Table S1. 50 immunomodulators. Table S2. Effector genes of TIICs. Table S3. Gene sets of therapeutic signatures. Table S4. Gene sets of cell death signatures. Table S7. Co-Expressed genes of NAPSB. Table S8. Upregulated expressed genes between NAPSB subgroups. Table S9. Common genes of co-expressed genes and upregulated DEGs. Table S10. Functional annotation and pathway analysis for common genes (Gene Ontology-Biological process). Table S11. Functional annotation and pathway analysis for common genes (KEGG pathways).